SciSparc Ltd. (SPRC) CTO clarifies 5,528 RSU-linked shares and option terms
Rhea-AI Filing Summary
SciSparc Ltd. reports updated equity holdings for Chief Technology Officer Adi Zuloff-Shani in an amendment to an earlier ownership statement. The amendment clarifies that the reported position represents 5,528 Ordinary Shares issuable upon the vesting of restricted share units, split between 5,000 RSUs vesting in quarterly installments of 625 shares through December 18, 2027 and 528 RSUs vesting in quarterly installments of 66 shares through June 20, 2026. It also restates option data, confirming a stock option covering 6 Ordinary Shares at an exercise price of 31941.0000, expiring January 3, 2028.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Zuloff-Shani Adi
Role
Chief Technology Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock option (right to buy) F2 | -- | -- | -- |
| holding | Ordinary Shares F1 | -- | -- | -- |
Holdings After Transaction:
Stock option (right to buy) — 6 shares (Direct);
Ordinary Shares — 5,528 shares (Direct)
Footnotes (2)
- F1. This Form is filed solely as an amendment to the Form 3 filed on March 18, 2026. This amendment amends and restates the first footnote in Table I as follows: "Includes (i) 5,000 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") in quarterly installments of 625 Ordinary Shares through December 18, 2027; and (ii) 528 Ordinary Shares issuable upon the vesting of RSUs in equal quarterly installments of 66 Ordinary Shares through June 20, 2026. Each RSU represents the right to receive one Ordinary Share." In addition, this amendment amends and restates Table II of the initial Form 3, as provided herein. No amendment is made hereby to any other footnotes of the initial Form 3.
- F2. This amendment amends and restates Table II of the initial Form 3, as provided herein. No amendment is made hereby to any other footnotes of the initial Form 3.
Key Figures
Ordinary Shares tied to RSUs: 5,528 Ordinary Shares
Primary RSU grant: 5,000 Ordinary Shares
Secondary RSU grant: 528 Ordinary Shares
+5 more
8 metrics
Ordinary Shares tied to RSUs
5,528 Ordinary Shares
Total Ordinary Shares issuable upon RSU vesting reported for the CTO
Primary RSU grant
5,000 Ordinary Shares
RSUs vesting in quarterly installments of 625 Ordinary Shares through December 18, 2027
Secondary RSU grant
528 Ordinary Shares
RSUs vesting in quarterly installments of 66 Ordinary Shares through June 20, 2026
Stock option underlying shares
6 Ordinary Shares
Underlying Ordinary Shares for the reported stock option (right to buy)
Option exercise price
31941.0000
Exercise price for the stock option expiring January 3, 2028
Option expiration date
January 3, 2028
Expiration date of the reported stock option (right to buy)
Quarterly vesting installment (primary RSUs)
625 Ordinary Shares
Size of each quarterly vesting installment for the 5,000-share RSU grant
Quarterly vesting installment (secondary RSUs)
66 Ordinary Shares
Size of each quarterly vesting installment for the 528-share RSU grant
Key Terms
restricted share units ("RSUs"), Ordinary Shares, stock option (right to buy)
3 terms
stock option (right to buy) financial
"Stock option (right to buy) over 6.0000 underlying Ordinary Shares"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What RSU vesting schedules does SciSparc (SPRC) detail for its CTO in this filing?
SciSparc describes two RSU grants: one for 5,000 Ordinary Shares vesting in quarterly installments of 625 shares through December 18, 2027, and another for 528 Ordinary Shares vesting in quarterly installments of 66 shares through June 20, 2026. Each RSU delivers one Ordinary Share.
What stock option position is reported for the SciSparc (SPRC) CTO in this Form 3/A?
The filing restates an option described as a stock option (right to buy) over 6 Ordinary Shares with an exercise price of 31941.0000 and an expiration date of January 3, 2028. The option is held directly by the reporting person.
Does this SciSparc (SPRC) Form 3/A amendment report any insider buying or selling?
No buying or selling is reported. The entries are classified as holding records, and the transaction summary shows 0 buys, 0 sells and 2 holding entries, indicating the amendment only corrects and restates previously reported ownership details.